Whether best multiplex ihc providers 2025 the tumor microenvironment in immuno-oncology, understanding wound healing or developmental tissues, or studying protein expression in complex diseases, multiplex IHC provides additional biological information that cannot be obtained with individual stains. However, spatially resolved multiplex IF assays pose unique challenges in clinical pathology: the number of analyzed biomarkers increases the risk of false positives and requires vigilance with regards to quality control.

IHC CRO Services: Partnering with Experts for Preclinical and Clinical Research

Fortunately, the barriers to the clinical adoption of mIF technology are not insurmountable. By implementing spatially resolved multicolor IF into routine anatomical pathology, laboratories can benefit from improved test sensitivity and specificity, better interpretation tools, and the ability to generate hypotheses that could not be generated using single-marker IHC. In order to optimize the performance of mIF assays, labs must carefully select protocols and image analysis software that will allow them to leverage pre-trained membrane and nuclear segmentation algorithms, set data-driven positivity thresholds, and dynamically explore colocalization and cell phenotypes.